Seminars in Thoracic and Cardiovascular Surgery
Volume 23, Issue 1 , Pages 5-7 , Spring 2011

Time for Coronary Artery Bypass Grafting to Make a Comeback?

  • David Taggart

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Lisa Jones, Department of Cardiovascular Surgery, University of Oxford, Oxford Heart Centre, 71 Plantation Road, Oxford OX2 6JE, United Kingdom

References 

  1. Mohr FW. SYNTAX 3VD: Three-year outcomes from a prospective randomized trial of paclitaxel-eluting stents compared to bypass graft surgery in patients with triple vessel coronary artery disease. Transcatheter Cardiovascular Therapeutics Symposium: Washington; 2010;
  2. Serruys PW. SYNTAX left main: Three-year outcomes from a prospective randomized trial of paclitaxel-eluting stents compared to bypass graft surgery in patients with left main coronary artery disease. Washington: Transcatheter Cardiovascular Therapeutics Symposium; 2010;
  3. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: A collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373:1190–1197
  4. Jeremias A, Kaul S, Rosengart TK, et al. The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med. 2009;122:152–161
  5. Taggart DP, Thomas BF. Lecture (Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know). Ann Thorac Surg. 2006;82:1966–1975
  6. Taggart DP. PCI or CABG in coronary artery disease?. Lancet. 2009;373:1150–1152
  7. Serruys PW, Morice MC, Kappetein AP, et al. ; SYNTAX Investigators: Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961–972
  8. Taggart DP, Kaul S, Boden WE, et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol. 2008;51:885–892
  9. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS): European Association for Percutaneous Cardiovascular Interventions (EAPCI), Kolh P, Wijns W, Danchin N, et al: Guidelines on myocardial revascularization. Eur J Cardiothorac Surg 38 Suppl:S1-S52, 2010

 Disclosure: Dr. Taggart reports receiving consulting fees from Medtronic, VGS, and AstroZeneca and lecture fees from Abbot Vascular.

PII: S1043-0679(11)00052-9

doi: 10.1053/j.semtcvs.2011.04.004

Seminars in Thoracic and Cardiovascular Surgery
Volume 23, Issue 1 , Pages 5-7 , Spring 2011